Unfair competition arising in the pharmaceutical markets and the presence of a shadow sector require the protection of the brand’s interests and confirmation of quality for the end customer. In recent years, the reaction to this has been the emergence of intercorporate methods of
More
The healthcare landscape is rapidly transforming, fueled by the convergence of technology
As we step into 2024, the global life science industry finds itself
The healthcare landscape is rapidly transforming, fueled by the convergence of technology and medicine. Among the myriad of innovations, the
MoreAs we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside
More
Unfair competition arising in the pharmaceutical markets and the presence of a shadow sector require the protection of the brand’s
More
